El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained

Buyer: sihtasutus Põhja-Eesti Regionaalhaigla

Open in El Vínculo
Published
17 September 2025
Submission deadline
21 October 2025, 10:00
Estimated value
€34,360,891
Place of performance
EE001
Procedure
Open procedure
Documents
1
Notice number
00606226-2025
Reference
a1d6bc37-19b8-4a30-93d2-3d2617d52f92
Official source
Official source

CPV codes

Description

Kasvajavastaste ainete, immunosupressantide, oftalmoloogias kasutatavate ainete, hingamisteede obstruktiivsete haiguste raviks kasutatavate ainete, migreenivastaste ainete ostmiseks / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest

Lots (41)

LotDescriptionCPV codeAmount
1 Panitumumab
EE001
 33600000 Productos farmacéuticos €46,700
2 Gemtuzumabosogamtsiin
EE001
 33600000 Productos farmacéuticos €54,070
3 Brentuksimabvedotiin
EE001
 33600000 Productos farmacéuticos €490,680
4 Pertuzumab
EE001
 33600000 Productos farmacéuticos €966,700
5 Trastuzumabemtansiin
EE001
 33600000 Productos farmacéuticos €1,973,300
6 Obinutuzumab
EE001
 33600000 Productos farmacéuticos €680,200
7 Nivolumab
EE001
 33600000 Productos farmacéuticos €3,096,600
8 Pembrolizumab
EE001
 33600000 Productos farmacéuticos €6,559,050
9 Blinatumomab
EE001
 33600000 Productos farmacéuticos €13,000
10 Daratumumab
EE001
 33600000 Productos farmacéuticos €8,372,000
11 Inotuzumabosogamitsiin
EE001
 33600000 Productos farmacéuticos €62,710
12 Durvalumab
EE001
 33600000 Productos farmacéuticos €878,350
13 Atezolisumab
EE001
 33600000 Productos farmacéuticos €2,478,000
14 Ipilimumab
EE001
 33600000 Productos farmacéuticos €1,006,950
15 Karfilsomiib
EE001
 33600000 Productos farmacéuticos €306,400
16 Iksasomiib
EE001
 33600000 Productos farmacéuticos €163,415
17 Pertuzumab + trastuzumab
EE001
 33600000 Productos farmacéuticos €1,617,000
18 Küüliku anti-T-lümfotsüütne immuunoglobuliin
EE001
 33600000 Productos farmacéuticos €18,100
19 Vedolizumab
EE001
 33600000 Productos farmacéuticos €254,000
20 Golimumab
EE001
 33600000 Productos farmacéuticos €292,600
21 Anakinra
EE001
 33600000 Productos farmacéuticos €9,600
22 Ustekinumab
EE001
 33600000 Productos farmacéuticos €159,100
23 Ustekinumab
EE001
 33600000 Productos farmacéuticos €30,000
24 Sarilumab
EE001
 33600000 Productos farmacéuticos €256,100
25 Belimumab
EE001
 33600000 Productos farmacéuticos €17,010
26 Belimumab
EE001
 33600000 Productos farmacéuticos €10,100
27 Polatuzumabvedotiin
EE001
 33600000 Productos farmacéuticos €847,000
28 Mogamulizumab
EE001
 33600000 Productos farmacéuticos €294,200
29 Trastuzumabderukstekaan
EE001
 33600000 Productos farmacéuticos €431,790
30 Mirikizumab
EE001
 33600000 Productos farmacéuticos €85,350

Award criteria

Official publications

Other tenders from sihtasutus Põhja-Eesti Regionaalhaigla

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 21 October 2025, 10:00. Check the official source, as dates can be modified.
What is the estimated value of this tender?
The estimated value published by the buyer is €34,360,891.
Who is the buyer of this tender?
The contracting authority is sihtasutus Põhja-Eesti Regionaalhaigla (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.